To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Inhaled THC demonstrated dose-dependent pain reduction and modest side effect 4 hours post-treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2018

Inhaled THC demonstrated dose-dependent pain reduction and modest side effect 4 hours post-treatment

Vol: 7| Issue: 9| Number:9| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy

J Pain. 2015 Jul;16(7):616-27. doi: 10.1016/j.jpain.2015.03.008

Contributing Authors:
JH Atkinson B Gouaux A T. D. U. M. S. M. Wallace

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

16 patients with pain due to diabetic peripheral neuropathy were randomly assigned to inhale either high dose, medium dose, low dose (7%, 4%, 1% by weight, respectively) of delta-9-tetrahydrocannabinol (THC), or placebo at the beginning each treatment session. The study consists of four 2-week treatment sessions, where participants received treatment at the beginning and used the remaining 2 weeks...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue